Related Experiment Videos
Endothelial cells can synthesize leukotriene B4
K D Nolan1, B A Keagy, F M Ramadan
1Department of Surgery, University of North Carolina, Chapel Hill 27599-7210.
Journal of Vascular Surgery
|September 1, 1990
Summary
Vascular endothelial cells can synthesize Leukotriene B4 (LTB4), a molecule implicated in atherosclerosis. This study confirms LTB4 production in cultured rabbit aortic endothelial cells using advanced analytical techniques.
Area of Science:
- Biochemistry
- Cell Biology
- Cardiovascular Research
Background:
- Leukotriene B4 (LTB4) is a lipid mediator potentially involved in atherosclerosis development.
- The capacity of vascular endothelium to synthesize LTB4 has been a subject of scientific debate.
Purpose of the Study:
- To definitively investigate and characterize the synthesis of LTB4 by endothelial cells.
- To resolve the controversy regarding endothelial LTB4 production in the context of atherosclerosis.
Main Methods:
- Cultured rabbit aortic endothelial cells were utilized to study arachidonic acid metabolism.
- High-pressure liquid chromatography (HPLC) and radioimmunoassay (RIA) were employed for metabolite identification and quantification.
- Cells were exposed to radiolabeled arachidonic acid and stimulated with calcium ionophore A23187.
Main Results:
- Three lipoxygenase metabolites of arachidonic acid were identified: LTB4, 12-hydroxyeicosatetraneoic acid, and 5-hydroxyeicosatetraneoic acid.
- LTB4 was further confirmed through spectral analysis and inhibition studies.
- Quantification revealed an average production of 600 pg LTB4 per 10^6 cells.
Conclusions:
- Rabbit aortic endothelial cells possess the enzymatic machinery to synthesize LTB4.
- These findings support a role for endothelial LTB4 in the pathogenesis of atherosclerotic lesions.